SEEQ™ Performance Study

Completed

Conditions studied: Arrhythmia Type Unknown

In brief

The purpose of the Medtronic SEEQ™ Performance study is to build further evidence on the clinical and economic benefit of the Medtronic market-released SEEQ™ Mobile Cardiac Telemetry System/External Cardiac Monitor System (MCT/ECM).

Key facts

Study ID

NCT02484898

Run by

Medtronic Cardiac Rhythm and Heart Failure

People needed

200

Starts

2015-06-01

Expected to finish

2016-08-01

Last updated by the study team

2016-11-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is indicated for a SEEQ™ MCT/ECM System for approved indications
• Patient is 18 years of age or older
• Patient is willing and able to provide consent and authorize the use and disclosure of health information
• Patient is willing and able to comply with the protocol

You may not qualify if…

• Patient has known allergy and/or hypersensitivity to adhesives or hydrogel.
• Patient has suspected potential life-threatening arrhythmias, or requires in-subject/in-hospital monitoring.
• Patient will undergo a medical procedure that would preclude full participate during the prescribed duration of the SEEQ™
• Patient has an implanted cardiac device, (e.g., pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy)

Where it is running

• Study site — Larkspur, California, United States
• Study site — Simi Valley, California, United States
• Study site — Aurora, Colorado, United States
• Study site — Clearwater, Florida, United States
• Study site — Palm Beach Gardens, Florida, United States
• Study site — Sebring, Florida, United States
• Study site — Rome, Georgia, United States
• Study site — Jackson, Mississippi, United States
• Study site — Henderson, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.